ArticleBMC cancer2017

Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.

Jon-Vidar Gaustad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.